<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(3)</volume><submitter>Lively S</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Up to 30% of spine facet osteoarthritis patients with lumbar spinal stenosis (SF-OA ​+ ​LSS) have little to no improvement in their pain after surgery. Lack of meaningful improvement in pain following surgery provides a unique opportunity to identify specific predictive biomarker signatures that might be associated with the outcomes of surgical treatment. The objective of the present study was to determine whether a microRNA (miRNA) biomarker signature could be identified in presurgical blood plasma that corresponded with levels of SF-OA ​+ ​LSS patient post-surgical pain intensity one year later.&lt;h4>Methods&lt;/h4>RNA was extracted from baseline plasma of SF-OA ​+ ​LSS patients and prepared for miRNA sequencing. Statistical approaches were performed to identify differentially expressed miRNAs associated with reduced 1-year postsurgical pain (n ​= ​56). Using an integrated computational approach, we further created predicted gene and pathway networks for each identified miRNA.&lt;h4>Results&lt;/h4>We identified a panel of 4 circulating candidate miRNAs (hsa-miR-155-5p, hsa-let-7e-5p, hsa-miR-125a-5p, hsa-miR-99b-5p) with higher levels at presurgical baseline that were associated with greater changes in % NPRS20Δ, reflecting reduced pain intensity levels at one year. Genes encoding hsa-let-7e-5p, hsa-miR-125a-5p, and hsa-miR-99b-5p are part of an evolutionarily conserved miRNA cluster. Using integrated computational analyses, we showed that mammalian target of rapamycin, transforming growth factor-β1 receptor, Wnt signaling, epithelial-mesenchymal transition regulators, and cholecystokinin signaling were enriched pathways of predicted gene targets.&lt;h4>Conclusions&lt;/h4>Taken together, our findings suggest that 4 presurgical baseline circulating miRNAs correlate with 1-year postsurgical SF-OA ​+ ​LSS patient pain intensity and represent possible candidate biomarker signature of surgical pain response.</pubmed_abstract><journal>Osteoarthritis and cartilage open</journal><pagination>100283</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9718249</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of presurgical circulating MicroRNAs with 1-year postsurgical pain reduction in spine facet osteoarthritis patients with lumbar spinal stenosis.</pubmed_title><pmcid>PMC9718249</pmcid><pubmed_authors>Layeghifard M</pubmed_authors><pubmed_authors>Endisha H</pubmed_authors><pubmed_authors>Espin-Garcia O</pubmed_authors><pubmed_authors>Kapoor M</pubmed_authors><pubmed_authors>Milliot M</pubmed_authors><pubmed_authors>Perruccio AV</pubmed_authors><pubmed_authors>Lively S</pubmed_authors><pubmed_authors>Potla P</pubmed_authors><pubmed_authors>Veillette C</pubmed_authors><pubmed_authors>Rampersaud YR</pubmed_authors><pubmed_authors>Sundararajan K</pubmed_authors><pubmed_authors>Nakamura A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of presurgical circulating MicroRNAs with 1-year postsurgical pain reduction in spine facet osteoarthritis patients with lumbar spinal stenosis.</name><description>&lt;h4>Purpose&lt;/h4>Up to 30% of spine facet osteoarthritis patients with lumbar spinal stenosis (SF-OA ​+ ​LSS) have little to no improvement in their pain after surgery. Lack of meaningful improvement in pain following surgery provides a unique opportunity to identify specific predictive biomarker signatures that might be associated with the outcomes of surgical treatment. The objective of the present study was to determine whether a microRNA (miRNA) biomarker signature could be identified in presurgical blood plasma that corresponded with levels of SF-OA ​+ ​LSS patient post-surgical pain intensity one year later.&lt;h4>Methods&lt;/h4>RNA was extracted from baseline plasma of SF-OA ​+ ​LSS patients and prepared for miRNA sequencing. Statistical approaches were performed to identify differentially expressed miRNAs associated with reduced 1-year postsurgical pain (n ​= ​56). Using an integrated computational approach, we further created predicted gene and pathway networks for each identified miRNA.&lt;h4>Results&lt;/h4>We identified a panel of 4 circulating candidate miRNAs (hsa-miR-155-5p, hsa-let-7e-5p, hsa-miR-125a-5p, hsa-miR-99b-5p) with higher levels at presurgical baseline that were associated with greater changes in % NPRS20Δ, reflecting reduced pain intensity levels at one year. Genes encoding hsa-let-7e-5p, hsa-miR-125a-5p, and hsa-miR-99b-5p are part of an evolutionarily conserved miRNA cluster. Using integrated computational analyses, we showed that mammalian target of rapamycin, transforming growth factor-β1 receptor, Wnt signaling, epithelial-mesenchymal transition regulators, and cholecystokinin signaling were enriched pathways of predicted gene targets.&lt;h4>Conclusions&lt;/h4>Taken together, our findings suggest that 4 presurgical baseline circulating miRNAs correlate with 1-year postsurgical SF-OA ​+ ​LSS patient pain intensity and represent possible candidate biomarker signature of surgical pain response.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-29T04:35:08.885Z</modification><creation>2025-04-06T14:09:39.631Z</creation></dates><accession>S-EPMC9718249</accession><cross_references><pubmed>36474943</pubmed><doi>10.1016/j.ocarto.2022.100283</doi></cross_references></HashMap>